Clinical approach and utilizing liquid biopsies to interrogate suspected acquired resistance to PD-1 blockade
Author(s)
De Silva, DL; Luo, J;
Details
Publication Year 2024,Volume 10,Issue #1,Page FSO937
Journal Title
Future Science OA
Publication Type
Case report
Abstract
PD-1 blockade is now routine for nearly all patients with non-small lung cancer. Acquired resistance to PD-1 blockade - defined generally as an initial response followed later by progression [(1-3)] is a common yet poorly understood concept. A key clinical challenge to insight has been a lack of standard guidance for clinical management of a case of suspected acquired resistance. The infrequency of performing tumor biopsies and the uncertainty of actionability from tissue sampling likely also contribute to limited insight into the biology of acquired resistance [4]. To address this knowledge gap and to highlight the value of tumor and liquid biopsy, we present a representative case of suspected acquired resistance to PD-1 blockade and propose a multi-modal guide for approaching this clinical scenario.
Publisher
Taylor & Francis
Department(s)
Medical Oncology
Open Access at Publisher's Site
https://doi.org/10.2144/fsoa-2023-0010
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-07-04 04:37:41
Last Modified: 2024-07-04 04:49:35

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙